Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | HCID 89544839 | HCID 89544839 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 89544968 | HCID 89544968 | — |
Reaction Steps
Step 2 To a stirred solution of N-[(1R)-1-{4-chloro-2-fluoro-3-[(pyridin-3-yl)carbonyl]phenyl}propyl]formamide (0.128 g, 0.399 mmol) in THF (2 mL) at room temperature was added BH3 in THF (1 M soln, 0.998 mL, 0.998 mmol) dropwise. The mixture was stirred at 50° C. overnight before it was quenched at 0° C. by the addition of excess MeOH followed by piperazine (0.352 g, 4.09 mmol). The mixture was stirred at room temperature for 1 hour before the solvents were removed under vacuum. The residue was taken into EtOAc, washed with water (×2), brine, dried (Na2SO4), filtered and concentrated providing {6-chloro-2-fluoro-3-[(1R)-1-(methylamino)propyl]-phenyl}(pyridin-3-yl)methanol which was used without further purification, 0.123 g, 100%. MS: [M+H]+ 309.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09145354B2 |
|---|
| Source dataset | uspto-grants-2015_09 |
|---|
| ORD ID | ord-5a9a826ce21b44f0b61c73e000a895fa |
|---|
| Source note | uspto-grants-2015_09 |
|---|